In the News

THCB Spotlights: Chris Gervais, CTO of Kyruus

Kyruus has grown quite a bit since it first started as a hospital appointment scheduling platform, and the company aims to continue that trend with its recent acquisition of HealthSparq. With this move, the company plans to bridge the gap between providers and payers and...

Survey Says Moms Want In-Person Care With a Side of Digital Health

Digital health company Xealth announced a recent survey examining new mothers and their expectations for digital health in comparison with the healthcare services they received. The survey was conducted among over 1,000 new or expectant mothers, with 57 percent of them showing a more favorable...

AI: Leveraging Wearables and Other Patient-Generated Data in Research

Luca Foschini, PhD, is chief data scientist and co-founder at Evidation Health. In a recent interview he discussed how artificial intelligence interacts with patient-generated data to create advancements in clinical studies for pharmaceutical and biotech companies. Smartphones and smartwatches are used daily around the world to...

Clinical Ink Acquires Digital Artefacts

Global clinical trial data and technology company Clinical Ink has announced its acquisition of Digital Artefacts, a digital technology company that specializes in data capture for complex cognitive, behavioral, and physiological research. “Data derived from Digital Artefacts can now increase the richness of our partners’ study...

Koneksa Broadens Multi-Year CNS Research Collaboration with Sanofi

Digital Biomarker company Koneksa announced an extension to its collaboration with Sanofi in central nervous system clinical trials. Sanofi is one of the world’s top biopharmaceutical companies, and Koneksa CEO Chris Benko expressed enthusiasm for the extension: “We’re proud that our long-term partnership has enabled...

How Hims & Hers built a business entirely centered on telehealth

Healthcare IT News recently interviewed Hims & Hers Chief Operating Officer Melissa Baird about how the company has built its brand around telehealth but still has its origins in helping people deal with conditions that are uncomfortable to talk about—sexual health, mental health, contraception, and...

FDA Selects Aetion Evidence Platform® to Advance Regulatory Science and Innovation

Aetion announced that it is expanding its relationship with the U.S. Food and Drug Administration to use real-world evidence to study COVID-19 interventions and advance regulatory science and innovation. The FDA and Aetion will use the Aetion Evidence Platform, validated software that enables efficient, transparent,...